rs61966074

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_000452.3(SLC10A2):​c.910T>C​(p.Phe304Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00352 in 1,613,794 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0027 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0036 ( 12 hom. )

Consequence

SLC10A2
NM_000452.3 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 0.339

Publications

10 publications found
Variant links:
Genes affected
SLC10A2 (HGNC:10906): (solute carrier family 10 member 2) This gene encodes a sodium/bile acid cotransporter. This transporter is the primary mechanism for uptake of intestinal bile acids by apical cells in the distal ileum. Bile acids are the catabolic product of cholesterol metabolism, so this protein is also critical for cholesterol homeostasis. Mutations in this gene cause primary bile acid malabsorption (PBAM); muatations in this gene may also be associated with other diseases of the liver and intestines, such as familial hypertriglyceridemia (FHTG). [provided by RefSeq, Mar 2010]
SLC10A2 Gene-Disease associations (from GenCC):
  • bile acid malabsorption, primary, 1
    Inheritance: AR, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0075482726).
BP6
Variant 13-103049298-A-G is Benign according to our data. Variant chr13-103049298-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 500243.
BS2
High Homozygotes in GnomAd4 at 2 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC10A2NM_000452.3 linkc.910T>C p.Phe304Leu missense_variant Exon 5 of 6 ENST00000245312.5 NP_000443.2 Q12908

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC10A2ENST00000245312.5 linkc.910T>C p.Phe304Leu missense_variant Exon 5 of 6 1 NM_000452.3 ENSP00000245312.3 Q12908

Frequencies

GnomAD3 genomes
AF:
0.00267
AC:
406
AN:
152184
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00101
Gnomad AMI
AF:
0.0296
Gnomad AMR
AF:
0.00229
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00123
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00422
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.00239
AC:
600
AN:
251066
AF XY:
0.00229
show subpopulations
Gnomad AFR exome
AF:
0.00105
Gnomad AMR exome
AF:
0.00361
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00120
Gnomad NFE exome
AF:
0.00347
Gnomad OTH exome
AF:
0.00490
GnomAD4 exome
AF:
0.00361
AC:
5277
AN:
1461492
Hom.:
12
Cov.:
31
AF XY:
0.00348
AC XY:
2530
AN XY:
727054
show subpopulations
African (AFR)
AF:
0.000867
AC:
29
AN:
33466
American (AMR)
AF:
0.00329
AC:
147
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26116
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39672
South Asian (SAS)
AF:
0.000313
AC:
27
AN:
86254
European-Finnish (FIN)
AF:
0.00120
AC:
64
AN:
53398
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5764
European-Non Finnish (NFE)
AF:
0.00436
AC:
4843
AN:
1111744
Other (OTH)
AF:
0.00273
AC:
165
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
265
530
795
1060
1325
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
198
396
594
792
990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00267
AC:
406
AN:
152302
Hom.:
2
Cov.:
32
AF XY:
0.00205
AC XY:
153
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.00101
AC:
42
AN:
41578
American (AMR)
AF:
0.00229
AC:
35
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.00123
AC:
13
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00422
AC:
287
AN:
68024
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
23
46
70
93
116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00311
Hom.:
2
Bravo
AF:
0.00280
TwinsUK
AF:
0.00378
AC:
14
ALSPAC
AF:
0.00415
AC:
16
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00314
AC:
27
ExAC
AF:
0.00251
AC:
305
EpiCase
AF:
0.00420
EpiControl
AF:
0.00302

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 05, 2018
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 01, 2016
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bile acid malabsorption, primary, 1 Uncertain:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

SLC10A2-related disorder Benign:1
Mar 25, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.34
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
2.0
DANN
Benign
0.74
DEOGEN2
Benign
0.072
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.53
T
M_CAP
Benign
0.0063
T
MetaRNN
Benign
0.0075
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
-0.040
N
PhyloP100
0.34
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.30
N
REVEL
Benign
0.019
Sift
Benign
0.36
T
Sift4G
Benign
0.99
T
Polyphen
0.0
B
Vest4
0.20
MutPred
0.38
Loss of sheet (P = 0.1907);
MVP
0.14
MPC
0.0047
ClinPred
0.0016
T
GERP RS
-0.079
Varity_R
0.033
gMVP
0.49
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61966074; hg19: chr13-103701648; API